Average Insider

Where insiders trade, we follow

$NRXS
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Healthcare
Sector
Biotechnology
Industry
Brian Carrico
CEO
21
Employees
$7.16
Current Price
$57.10M
Market Cap
52W Low$1.33
Current$7.1695.1% above low, 4.9% below high
52W High$7.46

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00---
Sells00--
2 monthsBuys12$382,800.0080,000All Buys
Sells00--
3 monthsBuys23$1,390,005.76366,138All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Feb 12, 2026
Hannasch Brian
10% Owner
Purchase40,000$4.92$196,800.00View Details
Feb 11, 2026
Hannasch Brian
10% Owner
Purchase40,000$4.65$186,000.00View Details
Dec 23, 2025
Aharon Gil
Director
Purchase286,138$3.52$1,007,205.76View Details
4 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Mar 19, 2026
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ€” create a free account to see 12 months of history

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.3.23